EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Combining β-Carotene with 5-FU via Polymeric Nanoparticles as a Novel Therapeutic Strategy to Overcome uL3-Mediated Chemoresistance in p53-Deleted Colorectal Cancer Cells

Pietro Carotenuto iD, Annalisa Pecoraro, Chiara Brignola iD, Anna Barbato, Brunella Franco, Giuseppe Longobardi, Claudia Conte, Fabiana Quaglia, Giulia Russo, Annapina Russo iD

Molecular Pharmaceutics · 01.05.2023 · 20 (5) · 2326-2340

DOI: 10.1021/acs.molpharmaceut.2c00876 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 28.03.2023. Verfasst von Pietro Carotenuto und 9 weiteren Autor:innen. Beteiligte Einrichtung: TIGEM, Telethon Institute of Genetics and Medicine, 80078 Naples, Italy. Hauptthemen laut MEDLINE: beta Carotene, Colorectal Neoplasms. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell?Istruzione, dell?Universit? e della Ricerca, Associazione Italiana per la Ricerca sul Cancro, H2020 Marie Sklodowska-Curie Actions.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) is one of the leading causes of cancer-related death worldwide. Despite recent therapeutic advancements, resistance to 5-fluorouracil (5-FU) remains a major obstacle to the successful treatment of this disease. We have previously identified the ribosomal protein uL3 as a key player in the cell response to 5-FU, and loss of uL3 is associated with 5-FU chemoresistance. Natural products, like carotenoids, have shown the ability to enhance cancer cell response to drugs and may provide a safer choice to defeat chemoresistance in cancer. Transcriptome analysis of a cohort of 594 colorectal patients revealed a correlation between uL3 expression and both progression-free survival and response to treatment. RNA-Seq data from uL3-silenced CRC cells demonstrated that a low uL3 transcriptional state was associated with an increased expression of specific ATP-binding cassette (ABC) genes. Using two-dimensional (2D) and three-dimensional (3D) models of 5-FU-resistant CRC cells stably silenced for uL3, we investigated the effect of a novel therapeutic strategy by combining β-carotene and 5-FU using nanoparticles (NPs) as a drug delivery system. Our results indicated that the combined treatment might overcome 5-FU chemoresistance, inducing cell cycle arrest in the G2/M phase and apoptosis. Furthermore, the combined treatment significantly reduced the expression levels of analyzed ABC genes. In conclusion, our findings suggest that β-carotene combined with 5-FU may be a more effective therapeutic approach for treating CRC cells with low levels of uL3.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta CaroteneColorectal NeoplasmsHumansTumor Suppressor Protein p53Drug Resistance, NeoplasmCell Line, TumorFluorouracilApoptosisGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

chemoresistancecolorectal cancernanoparticlesribosomal protein uL3β-carotene

Substanzen

beta CaroteneTumor Suppressor Protein p53Fluorouracil

Autor:innen und Institutionen

  • TIGEM, Telethon Institute of Genetics and Medicine, 80078 Naples, Italy.
  • Medical Genetics, Department of Translational Medical Science, University of Naples "Federico II", 80131 Naples, Italy.
  • Department of Pharmacy, University of Naples "Federico II", 80131 Naples, Italy.
  • Scuola Superiore Meridionale, School for Advanced Studies, 80138 Naples, Italy.

ORCID-Profile: Pietro Carotenuto, Chiara Brignola, Annapina Russo

Förderung

  • Ministero dell?Istruzione, dell?Universit? e della Ricerca
  • Associazione Italiana per la Ricerca sul Cancro
  • H2020 Marie Sklodowska-Curie Actions
  • Regione Campania

Zitieren

APA

Carotenuto, P., Pecoraro, A., Brignola, C., Barbato, A., Franco, B., Longobardi, G., Conte, C., Quaglia, F., Russo, G., & Russo, A. (2023). Combining β-Carotene with 5-FU via Polymeric Nanoparticles as a Novel Therapeutic Strategy to Overcome uL3-Mediated Chemoresistance in p53-Deleted Colorectal Cancer Cells. Molecular Pharmaceutics, 20(5), 2326-2340. https://doi.org/10.1021/acs.molpharmaceut.2c00876

Vancouver

Carotenuto P, Pecoraro A, Brignola C, Barbato A, Franco B, Longobardi G, et al. Combining β-Carotene with 5-FU via Polymeric Nanoparticles as a Novel Therapeutic Strategy to Overcome uL3-Mediated Chemoresistance in p53-Deleted Colorectal Cancer Cells. Molecular Pharmaceutics. 2023;20(5):2326-2340. doi:10.1021/acs.molpharmaceut.2c00876

BibTeX
@article{Carotenuto2023,
  author = {Carotenuto, Pietro and Pecoraro, Annalisa and Brignola, Chiara and Barbato, Anna and Franco, Brunella and Longobardi, Giuseppe and Conte, Claudia and Quaglia, Fabiana and Russo, Giulia and Russo, Annapina},
  title = {Combining β-Carotene with 5-FU via Polymeric Nanoparticles as a Novel Therapeutic Strategy to Overcome uL3-Mediated Chemoresistance in p53-Deleted Colorectal Cancer Cells},
  journal = {Molecular Pharmaceutics},
  year = {2023},
  volume = {20},
  number = {5},
  pages = {2326--2340},
  doi = {10.1021/acs.molpharmaceut.2c00876}
}
Kostenlos starten →